Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Is the P/B ratio high or low?

The P/B ratio of 3.14 is 17% above its 5-year average of 2.69, near the high end of its 5-year range (2.20–3.40).

8.00% above its 12-month average of 2.91.

P/E Ratio|ROE|Debt to Equity|All Metrics
DGX PB Ratio

DGX PB Ratio Chart

3.14
+7.90% 1Y
DGX PB Ratio

DGX Average PB Ratio Chart

DGX PB Ratio

DGX Current vs Average PB Ratio Chart

DGX PB Ratio Metrics

PB RATIO

3.14

PB RATIO AVG TTM

2.91

PB RATIO AVG 3Y

2.66

PB RATIO AVG 5Y

2.69

PB RATIO AVG 10Y

2.70

PB RATIO AVG 15Y

2.57

PB RATIO AVG 20Y

2.63

CURRENT VS TTM AVG

+8.00%

CURRENT VS 3Y AVG

+18.26%

CURRENT VS 5Y AVG

+16.61%

CURRENT VS 10Y AVG

+16.09%

CURRENT VS 15Y AVG

+22.00%

CURRENT VS 20Y AVG

+19.62%

DGX Competitors' PB Ratio

NAMEMARKET CAPPB RATIOTTM3Y5Y
Quest Diagnostics Incorporated (DGX)$22.83B3.142.912.662.69
BioNTech SE (BNTX)vs ›$22.76B1.051.131.152.32
United Therapeutics Corporation (UTHR)vs ›$23.07B4.353.282.702.61
Moderna, Inc. (MRNA)vs ›$23.71B3.191.682.064.77
Labcorp Holdings Inc. (LH)vs ›$21.83B2.532.602.412.24
Incyte Corporation (INCY)vs ›$21.48B4.014.013.593.95
Waters Corporation (WAT)vs ›$24.57B2.027.9413.6231.59
Mettler-Toledo International Inc. (MTD)vs ›$25.13BN/A1966.63623.56375.27
STERIS plc (STE)vs ›$20.52B2.883.353.453.41
Veeva Systems Inc. (VEEV)vs ›$25.68B3.595.686.698.88

P/B vs. its own history

At 3.14, P/B is richer than usual, sitting higher than 89% of its 20-year history.

20-year low

1.77

median

2.61

20-year high

4.44

cheaperricher

Book Value Analysis

P/B Ratio

3.14

Market Price / Book Value per Share

PB Ratio Formula & Definition

PB Ratio = Market Cap / Total Shareholders' Equity

The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Quest Diagnostics Incorporated (DGX)?
The P/B ratio for DGX stock is 3.14.
Is Quest Diagnostics Incorporated's P/B ratio high or low?
The P/B ratio of 3.14 is 17% above its 5-year average of 2.69, near the high end of its 5-year range (2.20–3.40).
What is the TTM average P/B ratio for Quest Diagnostics Incorporated (DGX)?
The TTM average P/B ratio for DGX stock is 2.91.
What is the 3Y average P/B ratio for Quest Diagnostics Incorporated (DGX)?
The 3Y average P/B ratio for DGX stock is 2.66.
What is the 5Y average P/B ratio for Quest Diagnostics Incorporated (DGX)?
The 5Y average P/B ratio for DGX stock is 2.69.
What is the 10Y average P/B ratio for Quest Diagnostics Incorporated (DGX)?
The 10Y average P/B ratio for DGX stock is 2.70.
What is the 15Y average P/B ratio for Quest Diagnostics Incorporated (DGX)?
The 15Y average P/B ratio for DGX stock is 2.57.
What is the 20Y average P/B ratio for Quest Diagnostics Incorporated (DGX)?
The 20Y average P/B ratio for DGX stock is 2.63.

DGX PB Ratio History

DATEPB RATIO
2026-06-253.14
2026-06-243.09
2026-06-233.00
2026-06-222.94
2026-06-182.96
2026-06-173.01
2026-06-163.06
2026-06-153.07
2026-06-123.09
2026-06-113.10
2026-06-103.10
2026-06-093.11
2026-06-083.00
2026-06-053.05
2026-06-042.98
2026-06-032.94
2026-06-022.94
2026-06-012.92
2026-05-292.96
2026-05-282.98
2026-05-272.95
2026-05-262.93
2026-05-222.97
2026-05-212.95
2026-05-202.95
2026-05-192.89
2026-05-182.89
2026-05-152.84
2026-05-142.86
2026-05-132.90
2026-05-122.89
2026-05-112.89
2026-05-082.85
2026-05-072.90
2026-05-062.88
2026-05-052.90
2026-05-042.91
2026-05-012.93
2026-04-302.95
2026-04-292.88
2026-04-282.97
2026-04-272.99
2026-04-242.98
2026-04-233.03
2026-04-223.10
2026-04-213.20
2026-04-203.07
2026-04-173.05
2026-04-162.99
2026-04-152.99
2026-04-143.03
2026-04-133.01
2026-04-102.99
2026-04-093.09
2026-04-083.11
2026-04-073.07
2026-04-063.11
2026-04-023.09
2026-04-013.09
2026-03-313.06
2026-03-303.08
2026-03-273.05
2026-03-263.10
2026-03-253.07
2026-03-243.06
2026-03-233.06
2026-03-203.05
2026-03-193.03
2026-03-183.05
2026-03-173.10
2026-03-163.11
2026-03-133.12
2026-03-123.14
2026-03-113.13
2026-03-103.14
2026-03-093.15
2026-03-063.11
2026-03-053.19
2026-03-043.26
2026-03-033.25
2026-03-023.28
2026-02-273.31
2026-02-263.30
2026-02-253.24
2026-02-243.26
2026-02-233.23
2026-02-203.15
2026-02-193.15
2026-02-183.18
2026-02-173.20
2026-02-133.22
2026-02-123.22
2026-02-113.26
2026-02-103.20
2026-02-092.98
2026-02-062.97
2026-02-052.99
2026-02-042.95
2026-02-032.88
2026-02-022.88
2026-01-302.91
2026-01-292.84
2026-01-282.85
2026-01-272.87
2026-01-262.84
2026-01-232.82
2026-01-222.84
2026-01-212.87
2026-01-202.94
2026-01-162.95
2026-01-152.96
2026-01-142.91
2026-01-132.80
2026-01-122.74
2026-01-092.72
2026-01-082.77
2026-01-072.77
2026-01-062.81
2026-01-052.70
2026-01-022.71
2025-12-312.70
2025-12-302.73
2025-12-292.73
2025-12-262.74
2025-12-242.74
2025-12-232.73
2025-12-222.75
2025-12-192.74
2025-12-182.74
2025-12-172.79
2025-12-162.78
2025-12-152.87
2025-12-122.84
2025-12-112.83
2025-12-102.79
2025-12-092.80
2025-12-082.83
2025-12-052.84
2025-12-042.87
2025-12-032.84
2025-12-022.84
2025-12-012.86
2025-11-282.95
2025-11-262.95
2025-11-252.99
2025-11-242.97
2025-11-212.98
2025-11-202.92
2025-11-192.90
2025-11-182.89
2025-11-172.90
2025-11-142.91
2025-11-132.92
2025-11-122.91
2025-11-112.94
2025-11-102.87
2025-11-072.79
2025-11-062.75
2025-11-052.78
2025-11-042.77
2025-11-032.78
2025-10-312.74
2025-10-302.74
2025-10-292.72
2025-10-282.78
2025-10-272.81
2025-10-242.84
2025-10-232.85
2025-10-222.82
2025-10-212.87
2025-10-202.98
2025-10-172.96
2025-10-162.92
2025-10-152.93
2025-10-142.90
2025-10-132.86
2025-10-102.88
2025-10-092.84
2025-10-082.83
2025-10-072.84
2025-10-062.79
2025-10-032.80
2025-10-022.83
2025-10-012.85
2025-09-302.98
2025-09-292.95
2025-09-262.95
2025-09-252.90
2025-09-242.92
2025-09-232.92
2025-09-222.89
2025-09-192.87
2025-09-182.87
2025-09-172.85
2025-09-162.82
2025-09-152.82
2025-09-122.86
2025-09-112.87
2025-09-102.82
2025-09-092.86
2025-09-082.85
2025-09-052.87
2025-09-042.82
2025-09-032.81
2025-09-022.79
2025-08-292.84
2025-08-282.80
2025-08-272.81
2025-08-262.82
2025-08-252.79
2025-08-222.82
2025-08-212.87
2025-08-202.88
2025-08-192.86
2025-08-182.80
2025-08-152.81
2025-08-142.79
2025-08-132.80
2025-08-122.79
2025-08-112.79
2025-08-082.77
2025-08-072.72
2025-08-062.70
2025-08-052.71
2025-08-042.70
2025-08-012.67
2025-07-312.62
2025-07-302.64
2025-07-292.63
2025-07-282.62
2025-07-252.64
2025-07-242.69
2025-07-232.67
2025-07-222.91
2025-07-212.71
2025-07-182.72
2025-07-172.74
2025-07-162.72
2025-07-152.71
2025-07-142.75
2025-07-112.74
2025-07-102.80
2025-07-092.83
2025-07-082.81
2025-07-072.84
2025-07-032.89
2025-07-022.88
2025-07-012.92
2025-06-302.93
2025-06-272.90
2025-06-262.89
2025-06-252.91
2025-06-242.93
2025-06-232.93
2025-06-202.93
2025-06-182.93
2025-06-172.92
2025-06-162.97
2025-06-132.94
2025-06-122.92

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

Related Metrics

P/E RatioROEDebt to EquityAll Metrics

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
www.questdiagnostics.com
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis
View full financials